Physician profile
Anthony Sanders
NPI 1689671885
$7,811.96
in general payments reported to CMS, 2019-2025
18 companies · $1,550 in 2025
The $1,550 reported for 2025 was more than what 86% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $629 · 2020: $1,834 · 2021: $731 · 2022: $610 · 2023: $1,452 · 2024: $1,005 · 2025: $1,550.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,989 · Entertainment: $18.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,988.65 |
| Entertainment | $18.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $2,313.08 | 2020-2025 | |
| Medtronic USA, INC. | $1,363.04 | 2019-2020 | |
| Stryker Corporation | $1,282.81 | 2019-2021 | |
| Spirair, INC. | $1,266.18 | 2024-2025 | Septalign |
| Medtronic, INC. | $432.37 | 2021-2024 | Propel, Nuvent |
| Glaxosmithkline, LLC. | $424.33 | 2022-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $307.51 | 2021-2025 | Dupixent |
| Genzyme Corporation | $109.74 | 2019-2025 | |
| Optinose US, INC. | $85.38 | 2019-2022 | |
| Acclarent, INC | $65.49 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $46.45 | 2020 | |
| Hologic Sales and Service, LLC | $23.43 | 2023 | Coolseal Generator |
| Arrinex, INC. | $19.76 | 2019 | |
| Merck Sharp & Dohme LLC | $16.33 | 2023 | |
| Pfizer INC. | $16.26 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $14.52 | 2023 | Oasis, Stravix, Grafix Pl |
| Exeltis, USA INC. | $13.01 | 2023 | Slynd |
| Kowa Pharmaceuticals America, INC. | $12.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Sanders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.